Dopamine agonist-induced hyperglycemia in rats: Structure-activity relationships and mechanisms of action
Authors:
- Michael J. SchmidtMSMichael J. Schmidt
- Mary A. RootMRMary A. Root
- James L. HallJHJames L. Hall
- 1 June 1983
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 90 (2-3) , 169-177
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Dopamine agonist-induced hyperglycemia in rats: Effects of lergotrile mesylateEuropean Journal of Pharmacology, 1979
- Effects of (8β)-8-[(Methylthio)methyl]-6-propylergoline on dopaminergic function and brain dopamine turnover in ratsLife Sciences, 1979
- Effect of lergotrile on3,4-dihydroxyphenylacetic acid (DOPAC) concentration and dopamine turnover in rat brainJournal of Neural Transmission, 1978
- On the Mechanism of Hyperglycemia and Stimulation of Growth Hormone Secretion by L-DopaPharmacology, 1978
- 3-Mercaptopicolinic acid, a preferential inhibitor of the cytosolic phosphoenolpyruvate carboxykinaseFEBS Letters, 1975
- Studies on the antiparkinsonian efficacy of lergotrileNeurology, 1975
- Regulation of Gluconeogenesis in the Guinea Pig LiverEuropean Journal of Biochemistry, 1970
- Studies of pancreatic alpha cell function in normal and diabetic subjectsJournal of Clinical Investigation, 1970
- On the hyperglycaemic effect of DOPA and dopamineEuropean Journal of Pharmacology, 1967
- A Paradoxical in Vivo Effect of L-Tryptophan on the Phosphoenolpyruvate Carboxykinase of Rat Liver*Biochemistry, 1966